Generic and Market Intrusion Insights
The introduction of the first generic product or a new brand with a new mechanism of action into a drug category can dramatically disrupt it or may only have a small impact, depending on product costs, which product is losing patent, and the size and stature of the remaining brands.
This report is based on secondary research coupled with primary research with key decision makers at important payer organizations and selected physicians.
Generic and Market Intrusion Insights is specifically geared toward
Generic and Market Intrusion Insights for each disease area is published once or twice each year, depending upon market conditions. A typical report consists of: